MLSS · Milestone Scientific Inc.

This 8-K discloses a significant executive compensation restructuring designed to address diminished incentive value of recently granted underwater stock options — a material governance and retention concern. The April 30, 2026 option exchange for CEO Eric Hines and SVP Jason Papes resets exercise prices from $0.45–$0.50 to $0.31 (the closing price on the Effective Date), preserving total share counts (2.0 million each) while accelerating vesting — delivering 25% upfront and front-loading the remainder over two years instead of three. This modification enhances near-term motivation without diluting shareholders, as no new shares are issued. Concurrently, the adoption of the 2026 Performance Incentive Sub-Plan introduces a rigorous, multi-year performance framework tied to organic sales growth ($11M–$15M), market capitalization ($50M), and strategic M&A — all requiring stockholder approval to increase the 2020 Plan’s share reserve. The 17.2 million-share Aggregate Pool is allocated across five milestones with strict forfeiture rules: no vesting for achievements within 12 months of grant, automatic forfeiture upon termination (except for pre-termination certified milestones), and full cancellation upon Change in Control except for already-certified achievements. The grants to Hines (30%), Harcum (17.5%), and Papes (17.5%) reflect tiered accountability, with Hines bearing primary responsibility for overall execution. Collectively, these actions signal a deliberate shift toward performance-based, long-term alignment — addressing investor concerns about prior equity grants’ ineffectiveness while introducing measurable, shareholder-approved value creation levers.